Galera Therapeutics, Inc. Common Stock
GRTX
GRTX was delisted on the 3rd of June, 2024.
33 hedge funds and large institutions have $18.1M invested in Galera Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 8 closing their positions.
32% more capital invested
Capital invested by funds: $13.7M → $18.1M (+$4.42M)
15% less funds holding
Funds holding: 39 → 33 (-6)
55% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 11
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$122K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$15.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$14.5K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$1.21K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$455 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$120K |
| 2 |
Two Sigma Advisers
New York
|
-$52K |
| 3 |
CM
Crestline Management
Fort Worth,
Texas
|
-$45K |
| 4 |
Two Sigma Investments
New York
|
-$30.7K |
| 5 |
Millennium Management
New York
|
-$24K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
US Bancorp
Minneapolis,
Minnesota
| $6K | – | – | – |
|
|
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $3.65K | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $3K | +$92 | +65 | +3% |
|
29
Morgan Stanley
New York
| $2K | -$4.28K | -3,025 | -74% |
|
30
Bank of America
Charlotte,
North Carolina
| $2K | -$2.85K | -2,019 | -69% |
|
|
31
Group One Trading
Chicago,
Illinois
| $1K | +$1.21K | +853 | New |
|
|
CM
32
Crestline Management
Fort Worth,
Texas
| – | -$45K | -34,305 | Closed |
|
|
33
Millennium Management
New York
| – | -$24K | -18,530 | Closed |
|
|
VF
34
Virtu Financial
New York
| – | -$19K | -14,491 | Closed |
|
35
Citigroup
New York
| – | -$15K | -11,599 | Closed |
|
36
Simplex Trading
Chicago,
Illinois
| – | -$2.44K | -1,729 | Closed |
|
|
FIA
37
FNY Investment Advisers
New York
| – | -$1K | -1,500 | Closed |
|
|
CG
38
Cutler Group
San Francisco,
California
| – | -$1.55K | -1,100 | -69% |
|
39
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$1K | -1,000 | Closed |
|
GRTX Hedge Fund Activity: Q3 2022 in Review
33 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q3 2022, worth a combined $18.1M — up 32% from $13.7M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of GRTX and 3 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 5 added.
The largest buyer was Geode Capital Management, adding an estimated $122K. The largest seller was Renaissance Technologies, cutting an estimated $120K.
- 33 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q3 2022, down from 39 in Q2 2022.
- Funds reported $18.1M of Galera Therapeutics, Inc. Common Stock stock for Q3 2022, up 32% quarter-over-quarter.
- 3 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q3 2022 and 8 closed out, a net change of -5 holders.
- The largest Galera Therapeutics, Inc. Common Stock buyer in Q3 2022 was Geode Capital Management, an estimated $122K added.
- The largest Galera Therapeutics, Inc. Common Stock seller in Q3 2022 was Renaissance Technologies, an estimated $120K sold.
Based on aggregated 13F filings for Q3 2022.